Invesco’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-298,564
| Closed | -$2.81M | – | 3873 |
|
|
2020
Q3 | $2.81M | Sell |
298,564
-40,364
| -12% | -$384K | ﹤0.01% | 2324 |
|
|
2020
Q2 | $2.59M | Sell |
338,928
-16,512
| -5% | -$126K | ﹤0.01% | 2348 |
|
|
2020
Q1 | $2.2M | Buy |
355,440
+52,055
| +17% | +$459K | ﹤0.01% | 2340 |
|
|
2019
Q4 | $3.69M | Buy |
303,385
+20,172
| +7% | +$220K | ﹤0.01% | 2337 |
|
|
2019
Q3 | $3.27M | Sell |
283,213
-41,937
| -13% | -$441K | ﹤0.01% | 2365 |
|
|
2019
Q2 | $3.25M | Sell |
325,150
-73,339
| -18% | -$791K | ﹤0.01% | 2432 |
|
|
2019
Q1 | $5.13M | Sell |
398,489
-65,758
| -14% | -$979K | ﹤0.01% | 1983 |
|
|
2018
Q4 | $7.05M | Sell |
464,247
-110,956
| -19% | -$2.11M | ﹤0.01% | 1747 |
|
|
2018
Q3 | $11.5M | Buy |
575,203
+211,440
| +58% | +$4.81M | ﹤0.01% | 1617 |
|
|
2018
Q2 | $7.09M | Buy |
363,763
+134,054
| +58% | +$2.97M | ﹤0.01% | 1912 |
|
|
2018
Q1 | $4.63M | Buy |
229,709
+84,228
| +58% | +$1.42M | ﹤0.01% | 2011 |
|
|
2017
Q4 | $1.93M | Buy |
145,481
+10,482
| +8% | +$158K | ﹤0.01% | 2615 |
|
|
2017
Q3 | $2.49M | Sell |
134,999
-1,367,753
| -91% | -$25.5M | ﹤0.01% | 2412 |
|
|
2017
Q2 | $27.7M | Buy |
1,502,752
+1,340,935
| +829% | +$26.6M | 0.01% | 1044 |
|
|
2017
Q1 | $3.65M | Buy |
161,817
+54,751
| +51% | +$1.31M | ﹤0.01% | 2201 |
|
|
2016
Q4 | $3.73M | Buy |
107,066
+7,840
| +8% | +$234K | ﹤0.01% | 2167 |
|
|
2016
Q3 | $2.43M | Sell |
99,226
-891
| -0.9% | -$22.3K | ﹤0.01% | 2418 |
|
|
2016
Q2 | $2.4M | Sell |
100,117
-732,414
| -88% | -$16.8M | ﹤0.01% | 2370 |
|
|
2016
Q1 | $19.5M | Buy |
832,531
+111,030
| +15% | +$2.64M | 0.01% | 1135 |
|
|
2015
Q4 | $21.8M | Buy |
721,501
+1,549
| +0.2% | +$50K | 0.01% | 1107 |
|
|
2015
Q3 | $28.6M | Sell |
719,952
-266,779
| -27% | -$16.6M | 0.01% | 984 |
|
|
2015
Q2 | $68.1M | Sell |
986,731
-14,394
| -1% | -$906K | 0.03% | 661 |
|
|
2015
Q1 | $54.7M | Buy |
1,001,125
+339,794
| +51% | +$16.2M | 0.02% | 765 |
|
|
2014
Q4 | $28.2M | Buy |
661,331
+660,649
| +96,869% | +$23.9M | 0.01% | 1044 |
|
|
2014
Q3 | $22K | Buy |
682
+3
| +0.4% | +$64 | ﹤0.01% | 3985 |
|
|
2014
Q2 | $14K | Hold |
679
| – | – | ﹤0.01% | 3984 |
|
|
2014
Q1 | $13K | Sell |
679
-134,543
| -99% | -$2.86M | ﹤0.01% | 4006 |
|
|
2013
Q4 | $3.28M | Buy |
135,222
+18,160
| +16% | +$427K | ﹤0.01% | 2314 |
|
|
2013
Q3 | $2.51M | Buy |
117,062
+38,010
| +48% | +$898K | ﹤0.01% | 2376 |
|
|
2013
Q2 | $1.76M | Buy |
+79,052
| New | +$1.74M | ﹤0.01% | 2473 |
|
Invesco's AMAG Position: Q4 2020 in Review
Invesco sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 298,564 shares — an estimated $2.81M sold.
Invesco first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $68.1M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Invesco reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Invesco sold 298,564 AMAG Pharmaceuticals shares in Q4 2020, an estimated $2.81M.
- Invesco first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Invesco's AMAG Pharmaceuticals position peaked at $68.1M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Invesco's 13F filing for Q4 2020, filed 16 Feb 2021.